Literature DB >> 18332062

Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.

R D Lopes1, K S Pieper, J R Horton, S M Al-Khatib, L K Newby, R H Mehta, F Van de Werf, P W Armstrong, K W Mahaffey, R A Harrington, E M Ohman, H D White, L Wallentin, C B Granger.   

Abstract

OBJECTIVE: To assess variables associated with the occurrence of atrial fibrillation (AF) and the relation of AF with short- and long-term outcomes and with other in-hospital complications in patients with acute coronary syndromes (ACS) with and without ST-segment elevation.
DESIGN: Pooled database of 120 566 patients with ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation (NSTE) ACS enrolled in 10 clinical trials. Multivariable logistic regression and Cox proportional hazards modelling were used to identify factors associated with AF and its relation with clinical outcomes.
SETTING: ACS complicated by AF. PATIENTS: 120,566 patients with STEMI and NSTE-ACS in 10 clinical trials.
INTERVENTIONS: None evaluated. MAIN OUTCOME MEASURE: Short- and long-term mortality.
RESULTS: Occurrence of AF was 7.5% in the overall population (STEMI 8.0% (n = 84 161); NSTE-ACS = 6.4% (n = 36,405)). Seven-day mortality was higher for patients with AF (5.1%) than for those without (1.6%). After adjusting for confounders, association of AF with 7-day mortality was present in STEMI (hazards ratio (HR) = 1.65; 95% CI 1.44 to 1.90) and NSTE-ACS (HR = 2.30; 95% CI 1.83 to 2.90; p interaction = 0.015). Risk of long-term mortality (day 8 to 1 year) was also higher in STEMI (HR = 2.37; 95% CI 1.79 to 3.15) and NSTE-ACS (HR = 1.67; 95% CI 1.41 to 1.99). AF had a larger impact in NSTE-ACS on risk of short-term mortality (p<0.001), stroke (p<0.001), ischaemic stroke (p<0.001) and moderate or severe bleeding (p<0.001).
CONCLUSIONS: AF is more common in patients with STEMI. An association of AF with short- and long-term mortality among patients with STEMI and NSTE-ACS was found. Understanding these findings may lead to better care of patients with this common arrhythmia.

Entities:  

Mesh:

Year:  2008        PMID: 18332062     DOI: 10.1136/hrt.2007.134486

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  53 in total

1.  Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction.

Authors:  Artur Dziewierz; Dawid Giszterowicz; Zbigniew Siudak; Tomasz Rakowski; Jacek S Dubiel; Dariusz Dudek
Journal:  Clin Res Cardiol       Date:  2010-05-11       Impact factor: 5.460

Review 2.  Antithrombotic therapy in atrial fibrillation: guidelines translated for the clinician.

Authors:  Renato D Lopes; Jonathan P Piccini; Elaine M Hylek; Christopher B Granger; John H Alexander
Journal:  J Thromb Thrombolysis       Date:  2008-09-21       Impact factor: 2.300

3.  Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease.

Authors:  Benjamin A Steinberg; Samuel H Broderick; Renato D Lopes; Linda K Shaw; Kevin L Thomas; Tracy A DeWald; James P Daubert; Eric D Peterson; Christopher B Granger; Jonathan P Piccini
Journal:  Europace       Date:  2014-04-21       Impact factor: 5.214

Review 4.  Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention.

Authors:  David D McManus; Amir Y Shaikh; Fnu Abhishek; Ramachandran S Vasan
Journal:  Crit Pathw Cardiol       Date:  2011-03

5.  Combined use of warfarin and oral P2Y12 inhibitors in patients with atrial fibrillation and acute coronary syndrome.

Authors:  W Schuyler Jones; Xiaojuan Mi; Manesh R Patel; Roger Mills; Adrian F Hernandez; Lesley H Curtis
Journal:  Clin Cardiol       Date:  2013-12-11       Impact factor: 2.882

Review 6.  Evolving cardiovascular uses of direct-acting oral anticoagulants: a paradigm shift on the horizon?

Authors:  Emanuel Raschi; Matteo Bianchin; Cecilia Fantoni; Walter Ageno; Fabrizio De Ponti; Roberto De Ponti
Journal:  Intern Emerg Med       Date:  2017-08-07       Impact factor: 3.397

Review 7.  Post-PCI Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation.

Authors:  Mahesh V Madhavan; Ajay J Kirtane
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

8.  Trends in atrial fibrillation in patients hospitalized with an acute coronary syndrome.

Authors:  David D McManus; Wei Huang; Kunal V Domakonda; Jeanine Ward; Jane S Saczysnki; Joel M Gore; Robert J Goldberg
Journal:  Am J Med       Date:  2012-11       Impact factor: 4.965

9.  Trends in atrial fibrillation complicating acute myocardial infarction.

Authors:  Jane S Saczynski; David McManus; Zheng Zhou; Frederick Spencer; Jorge Yarzebski; Darleen Lessard; Joel M Gore; Robert J Goldberg
Journal:  Am J Cardiol       Date:  2009-06-03       Impact factor: 2.778

10.  Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry.

Authors:  Benjamin A Steinberg; Sunghee Kim; Jonathan P Piccini; Gregg C Fonarow; Renato D Lopes; Laine Thomas; Michael D Ezekowitz; Jack Ansell; Peter Kowey; Daniel E Singer; Bernard Gersh; Kenneth W Mahaffey; Elaine Hylek; Alan S Go; Paul Chang; Eric D Peterson
Journal:  Circulation       Date:  2013-07-16       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.